Evidence map›Paper›PMID 30416759›Full record

ArticleNature reviews. Materials2018

Biomaterials to model and measure epithelial cancers.

Pranjali Beri, Bibiana F Matte, Laurent Fattet, Daehwan Kim, Jing Yang, Adam J Engler

Abstract read
In one paragraph

Article in Nature reviews. Materials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Biomaterial-basedCancer pathogenesis and therapy · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Biomaterials for Mimicking and Modelling Tumor Microenvironment.Advances in experimental medicine and biology · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Microrheology for biomaterial design.APL bioengineering · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pranjali BeriDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
Bibiana F MatteDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
Laurent FattetDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Daehwan KimDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Jing YangDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Adam J EnglerDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, USA.ORCID https://orcid.org/0000-0003-1642-5380

Funding

Biomaterial Mimicry of Dynamic Matrix Stiffening During Tumor ProgressionR01CA206880 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ENGLER, ADAM J, YANG, JING · 2016 to 2020
$1.8M
Developing Adhesome Technology as a Physical Marker of Highly Metastatic CellsR21CA217735 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ENGLER, ADAM J · 2018 to 2020
$623k
NCI NIH HHS R01 CA206880NCI NIH HHS R21 CA217735
6 · The paper itself

Abstract

The use of biomaterials has substantially contributed to both our understanding of tumorigenesis and our ability to identify and capture tumour cells in vitro and in vivo. Natural and synthetic biomaterials can be applied as models to recapitulate key features of the tumour microenvironment in vitro, including architectural, mechanical and biological functions. Engineered biomaterials can further mimic the spatial and temporal properties of the surrounding tumour niche to investigate the specific effects of the environment on disease progression, offering an alternative to animal models for the testing of cancer cell behaviour. Biomaterials can also be used to capture and detect cancer cells in vitro and in vivo to monitor tumour progression. In this Review, we discuss the natural and synthetic biomaterials that can be used to recreate specific features of tumour microenvironments. We examine how biomaterials can be applied to capture circulating tumour cells in blood samples for the early detection of metastasis. We highlight biomaterial-based strategies to investigate local regions adjacent to the tumour and survey potential applications of biomaterial-based devices for diagnosis and prognosis, such as the detection of cellular deformability and the non-invasive surveillance of tumour-adjacent stroma.

Identifiers

PMID30416759
PMCPMC6224155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.